-
Asieris Announces First Patient Administration in the Global Phase III Clinical Trial for APL-1702
prnasia
November 13, 2020
Asieris Pharmaceuticals, a China-based biotech company with global aspirations to discover, develop, and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today that the first patient was enrolled ...
-
AMU targets 1000 volunteers for phase-III trial of Covaxin
expresspharma
November 12, 2020
Volunteers will be given transportation, and other care, as well as precautions, will be taken, as endorsed in the guidelines for clinical trials, assures university.
-
PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period
prnasia
November 06, 2020
PolyActiva Pty Ltd, a clinical-stage Australian ophthalmology biopharmaceutical company, announced it has successfully completed its Phase I clinical study for its lead candidate, the Latanoprost FA SR Ocular Implant.
-
Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress
prnewswire
October 29, 2020
Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced the Company has begun recruiting and enrolling patients in ...
-
BiondVax Universal Influenza Vaccine Candidate Trial Does Not Meet Primary, Secondary Endpoints
americanpharmaceuticalreview
October 29, 2020
BiondVax Pharmaceuticals announced topline data from the Company's pivotal, phase 3 clinical trial of M-001 as a standalone universal flu vaccine candidate.
-
Thermo Fisher Expands Direct-to-Patient Service
contractpharma
October 29, 2020
Offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable medication delivery directly to patients' homes.
-
Thermo Fisher Launches Expanded Direct-to-Patient Service
contractpharma
October 29, 2020
Offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable medication delivery directly to patients' homes.
-
Oxeia Initiates Trial for OXE103 for Concussions
americanpharmaceuticalreview
October 28, 2020
Oxeia Biopharmaceuticals announced the initiation of a Phase 2 clinical trial of OXE103 for treating concussion. The Phase 2 clinical study is being conducted by Dr. Michael Rippee, an assistant professor of neurology at the ...
-
Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V in India
expresspharma
October 19, 2020
This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study.
-
Trial supports use of fluvoxamine in patients with mild COVID-19
europeanpharmaceuticalreview
October 16, 2020
A clinical trial has demonstrated that the likelihood of hospitalisation was significantly reduced for patients with mild COVID-19 when given fluvoxamine.